Understanding the Impacts of Surface Compositions on the In-Vitro Dissolution and Aerosolization of Co-Spray-Dried Composite Powder Formulations for Inhalation

[1] Mizgerd JP(2006)Lung infection--a public health priority PLoS Med 3 e76-295

[2] Hill AT(2000)Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis Am J Med 109 288-1095

[3] Campbell EJ(2003)Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 167 1090-764

[4] Hill SL(2002)Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations Thorax 57 759-82

[5] Bayley DL(2015)Inhaled anti-infective chemotherapy for respiratory tract infections: Successes, challenges and the road ahead Adv Drug Deliv Rev 85 65-905

[6] Stockley RA(2009)Delivery of antibiotics to the respiratory tract: an update Expert Opin Drug Deliv 6 897-3294

[7] Wilkinson TM(2011)Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients Antimicrob Agents Chemother 55 3284-5095

[8] Patel IS(2013)Population pharmacokinetics of colistin methanesulfonate in rats: Achieving sustained lung concentrations of colistin for targeting respiratory infections Antimicrob Agents Chemother 57 5087-663

[9] Wilks M(2013)Inhaled antibiotics to treat lung infection Pharm Pat Anal 2 647-1155

[10] Donaldson GC(2010)Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa Intensive Care Med 36 1147-1615

[1] Mizgerd JP(2006)Lung infection--a public health priority PLoS Med 3 e76-295

[2] Hill AT(2000)Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis Am J Med 109 288-1095

[3] Campbell EJ(2003)Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 167 1090-764

[4] Hill SL(2002)Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations Thorax 57 759-82

[5] Bayley DL(2015)Inhaled anti-infective chemotherapy for respiratory tract infections: Successes, challenges and the road ahead Adv Drug Deliv Rev 85 65-905

[6] Stockley RA(2009)Delivery of antibiotics to the respiratory tract: an update Expert Opin Drug Deliv 6 897-3294

[7] Wilkinson TM(2011)Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients Antimicrob Agents Chemother 55 3284-5095

[8] Patel IS(2013)Population pharmacokinetics of colistin methanesulfonate in rats: Achieving sustained lung concentrations of colistin for targeting respiratory infections Antimicrob Agents Chemother 57 5087-663

[9] Wilks M(2013)Inhaled antibiotics to treat lung infection Pharm Pat Anal 2 647-1155

[10] Donaldson GC(2010)Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa Intensive Care Med 36 1147-1615